BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23176242)

  • 1. Insulin glargine treatment of a ferret with diabetes mellitus.
    Hess L
    J Am Vet Med Assoc; 2012 Dec; 241(11):1490-4. PubMed ID: 23176242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glargine insulin for treatment of naturally occurring diabetes mellitus in dogs.
    Hess RS; Drobatz KJ
    J Am Vet Med Assoc; 2013 Oct; 243(8):1154-61. PubMed ID: 24094263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of insulin glargine in dogs with diabetes mellitus.
    Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
    Vet Rec; 2012 Jan; 170(2):52. PubMed ID: 22008227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant rate infusion of glucagon as an emergency treatment for hypoglycemia in a domestic ferret (Mustela putorius furo).
    Bennett KR; Gaunt MC; Parker DL
    J Am Vet Med Assoc; 2015 Feb; 246(4):451-4. PubMed ID: 25632820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Henley K; Cole C;
    J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin therapy in cats with diabetes mellitus.
    Moise NS; Reimers TJ
    J Am Vet Med Assoc; 1983 Jan; 182(2):158-64. PubMed ID: 6298164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detemir insulin for the treatment of diabetes mellitus in dogs.
    Fracassi F; Corradini S; Hafner M; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
    J Am Vet Med Assoc; 2015 Jul; 247(1):73-8. PubMed ID: 26086231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
    Marshall RD; Rand JS; Morton JM
    J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM
    J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study of protamine zinc recombinant insulin for the treatment of diabetes mellitus in cats.
    Norsworthy G; Lynn R; Cole C
    Vet Ther; 2009; 10(1-2):24-8. PubMed ID: 19742445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of glargine and lente insulins in cats with diabetes mellitus.
    Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
    J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic pancreatitis with secondary diabetes mellitus treated by use of insulin in an adult California sea lion.
    Meegan JM; Sidor IF; Steiner JM; Sarran D; Dunn JL
    J Am Vet Med Assoc; 2008 Jun; 232(11):1707-12. PubMed ID: 18518815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of insulin glargine during pregnancy.
    Pöyhönen-Alho M; Rönnemaa T; Saltevo J; Ekblad U; Kaaja RJ
    Acta Obstet Gynecol Scand; 2007 Oct; 86(10):1171-4. PubMed ID: 17851816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M; Tapanainen P; Veijola R
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
    Maggiore AD; Nelson RW; Dennis J; Johnson E; Kass PH
    J Vet Intern Med; 2012; 26(1):109-15. PubMed ID: 22211582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.